Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9028)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 27, 2021 (publication date) through Jun 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Surgery
ISSN
1948-9366
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Fernandez CJ, Agarwal M, Pottakkat B, Haroon NN, George AS, Pappachan JM. Gastroenteropancreatic neuroendocrine neoplasms: A clinical snapshot. World J Gastrointest Surg 2021; 13(3): 231-255 [PMID: 33796213 DOI: 10.4240/wjgs.v13.i3.231] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9366/full/v13/i3/231.htm |
| Number | Citing Articles |
| 1 |
Christopher Sakellis, Heather A. Jacene. Neuroendocrine Tumors. PET Clinics 2024; 19(3): 325 doi: 10.1016/j.cpet.2024.03.008
|
| 2 |
Wei Wang, Bo Zhang, Yue Zhang, Pinyi Ma, Xinghua Wang, Ying Sun, Daqian Song, Qiang Fei. Colorimetry and SERS dual-mode sensing of serotonin based on functionalized gold nanoparticles. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2021; 261: 120057 doi: 10.1016/j.saa.2021.120057
|
| 3 |
Andrew Canakis, Linda S Lee. Current updates and future directions in diagnosis and management of gastroenteropancreatic neuroendocrine neoplasms. World Journal of Gastrointestinal Endoscopy 2022; 14(5): 267-290 doi: 10.4253/wjge.v14.i5.267
|
| 4 |
D. A. Salimgereeva, I. Y. Feidorov, I. E. Khatkov. Pancreatic resections or observation in management of sporadic non-functioning stage T1 neuroendocrine tumors of the pancreas (PNET) (literature review). Endocrine Surgery 2023; 17(1): 35 doi: 10.14341/serg12775
|
| 5 |
Catherine H. Davis, Amanda M. Laird, Steven K. Libutti. Resistant gastroenteropancreatic neuroendocrine tumors: a definition and guideline to medical and surgical management. Baylor University Medical Center Proceedings 2024; 37(1): 104 doi: 10.1080/08998280.2023.2284039
|
| 6 |
Efstathios Theodoros Pavlidis, Theodoros Efstathios Pavlidis. Molecular factors, diagnosis and management of gastrointestinal tract neuroendocrine tumors: An update. World Journal of Clinical Cases 2022; 10(27): 9573-9587 doi: 10.12998/wjcc.v10.i27.9573
|
| 7 |
Juni Banerjee, Ramya P. Ranjan, Md. Tanjim Alam, Sanika Deshmukh, Prem Prakash Tripathi, Sonu Gandhi, Shuvomoy Banerjee. Virus-associated neuroendocrine cancers: Pathogenesis and current therapeutics. Pathology - Research and Practice 2023; 248: 154720 doi: 10.1016/j.prp.2023.154720
|
| 8 |
Kamran Shateri, Fatemeh Halimi shabestari, Mohammad Reza Pashaei. Gallstone Frequency in Adults With Celiac Disease: Results of a Population-Based Celiac Disease Registry From West Azerbaijan, IRAN. Disease and Diagnosis 2022; 11(1): 14 doi: 10.34172/ddj.2022.04
|
| 9 |
Niko Hiltunen, Jukka Rintala, Juha P. Väyrynen, Jan Böhm, Tuomo J. Karttunen, Heikki Huhta, Olli Helminen. Monocarboxylate Transporters 1 and 4 and Prognosis in Small Bowel Neuroendocrine Tumors. Cancers 2022; 14(10): 2552 doi: 10.3390/cancers14102552
|
| 10 |
Giuseppe Iabichino, Milena Di Leo, Monica Arena, Giovanni Giuseppe Rubis Passoni, Elisabetta Morandi, Francesca Turpini, Paolo Viaggi, Carmelo Luigiano, Luca De Luca. Diagnosis, treatment, and current concepts in the endoscopic management of gastroenteropancreatic neuroendocrine neoplasms. World Journal of Gastroenterology 2022; 28(34): 4943-4958 doi: 10.3748/wjg.v28.i34.4943
|
| 11 |
Heying Duan, Andrei Iagaru. Neuroendocrine Tumor Diagnosis. PET Clinics 2023; 18(2): 259 doi: 10.1016/j.cpet.2022.11.008
|
| 12 |
Niko Hiltunen, Juha P. Väyrynen, Jan Böhm, Olli Helminen. CD3+, CD8+, CD4+ and FOXP3+ T Cells in the Immune Microenvironment of Small Bowel Neuroendocrine Tumors. Diseases 2021; 9(2): 42 doi: 10.3390/diseases9020042
|
| 13 |
Matteo Regolo, Nicolas Cardaci, Clara Salmeri, Alfredo Laudani, Michele Colaci, Massimo Ippolito, Fabio Motta, Salvatore Magrì, Stefanie Parisi, Alfredo Gaetano Torcitto, Lorenzo Malatino. Pancreatic Neuroendocrine Tumor (Pan-NET) Presented by Abdominal Pain: A Case Report and Literature Review. Journal of Clinical Medicine 2023; 12(20): 6617 doi: 10.3390/jcm12206617
|
| 14 |
Cecilie Slott, Seppo W. Langer, Stine Møller, Jesper Krogh, Marianne Klose, Carsten Palnæs Hansen, Andreas Kjaer, Pernille Holmager, Rajendra Singh Garbyal, Ulrich Knigge, Mikkel Andreassen. Outlook for 615 Small Intestinal Neuroendocrine Tumor Patients: Recurrence Risk after Surgery and Disease-Specific Survival in Advanced Disease. Cancers 2024; 16(1): 204 doi: 10.3390/cancers16010204
|
| 15 |
Federica De Muzio, Fabio Pellegrino, Roberta Fusco, Salvatore Tafuto, Mariano Scaglione, Alessandro Ottaiano, Antonella Petrillo, Francesco Izzo, Vincenza Granata. Prognostic Assessment of Gastropancreatic Neuroendocrine Neoplasm: Prospects and limits of Radiomics. Diagnostics 2023; 13(18): 2877 doi: 10.3390/diagnostics13182877
|
| 16 |
Niko Hiltunen, Niko Kemi, Juha P. Väyrynen, Jan Böhm, Joonas H. Kauppila, Heikki Huhta, Olli Helminen, Luwen Zhang. Toll-like receptors 1–9 in small bowel neuroendocrine tumors–Clinical significance and prognosis. PLOS ONE 2024; 19(5): e0302813 doi: 10.1371/journal.pone.0302813
|
| 17 |
Sanjana Ballal, Madhav P. Yadav, Madhavi Tripathi, Ranjit Kumar Sahoo, Chandrasekhar Bal. Survival Outcomes in Metastatic Gastroenteropancreatic Neuroendocrine Tumor Patients Receiving Concomitant225Ac-DOTATATE–Targeted α-Therapy and Capecitabine: A Real-World-Scenario Management-Based Long-Term Outcome Study. Journal of Nuclear Medicine 2023; 64(2): 211 doi: 10.2967/jnumed.122.264043
|
| 18 |
Ludovica Magi, Matteo Marasco, Maria Rinzivillo, Antongiulio Faggiano, Francesco Panzuto. Management of Functional Pancreatic Neuroendocrine Neoplasms. Current Treatment Options in Oncology 2023; 24(7): 725 doi: 10.1007/s11864-023-01085-0
|
| 19 |
Emma N. Rizen, Alexandria T. Phan. Neuroendocrine Tumors: a Relevant Clinical Update. Current Oncology Reports 2022; 24(6): 703 doi: 10.1007/s11912-022-01217-z
|
| 20 |
Francesca Corti, Roberta Elisa Rossi, Pietro Cafaro, Gaia Passarella, Antonella Turla, Sara Pusceddu, Jorgelina Coppa, Simone Oldani, Alessandro Guidi, Raffaella Longarini, Diego Luigi Cortinovis. Emerging Treatment Options for Neuroendocrine Neoplasms of Unknown Primary Origin: Current Evidence and Future Perspectives. Cancers 2024; 16(11): 2025 doi: 10.3390/cancers16112025
|
| 21 |
Vijay W. Dhakre, Sneha Tukaram Galande, Varsha Gunvant Patil, Nikita C. Shah, Chetan Rathod, Kaiumarz S. Sethna, Anjali D. Amrapurkar. Mixed Neuroendocrine and Non-Neuroendocrine Neoplasm of Pancreas: What Do We Know, What Have We Learnt?. Gastrointestinal Tumors 2023; 10(1): 14 doi: 10.1159/000528759
|
| 22 |
Vincent Hautefeuille, Thomas Walter, Christine Do Cao, Romain Coriat, Sophie Dominguez, Laurent Mineur, Guillaume Cadiot, Eric Terrebonne, Iradj Sobhani, Delphine Gueguen, Aude Houchard, Charbel Mouawad, Amélie Anota, Pascal Hammel. OPERA: perception of information in patients with gastroenteropancreatic neuroendocrine tumors on lanreotide autogel. European Journal of Endocrinology 2023; 189(2): 281 doi: 10.1093/ejendo/lvad094
|